Anabolic agent use in adults with cystic fibrosis
Tài liệu tham khảo
Cohen, 2007, A league of their own: demographics, motivations and patterns of use of 1,995 male adult non-medical anabolic steroid users in the United States, J Int Soc Sport Nutr., 4
Korkia, 1997, Indications of prevalence, practice and effects of anabolic steroid use in Great Britain, Int J Sports Med., 18, 557, 10.1055/s-2007-972681
Pinquart, 2013, Body image of children and adolescents with chronic illness: a meta-analytic comparison with healthy peers, Body Image., 10, 141, 10.1016/j.bodyim.2012.10.008
Elkin, 2000, Relationship of skeletal muscle mass, muscle strength and bone mineral density in adults with cystic fibrosis Study subjects, Clin Sci., 99, 309, 10.1042/cs0990309
Didsbury J, Thackray E. Cystic Fibrosis and Body Image, a Collection of Real Life Experiences. 2010.
Orr, 2004, The Anabolic Androgenic Steroid Oxandrolone in the Treatment of Wasting and Catabolic Disorders, Drugs., 64, 725, 10.2165/00003495-200464070-00004
Fried, 1968, The Erythropoietic-Stimulating Effects of Androgens, Ann N Y Acad Sci., 149, 356, 10.1111/j.1749-6632.1968.tb15169.x
Kasperk, 1989, Androgens directly stimulate proliferation of bone cells in vitro, Endocrinology., 124, 1576, 10.1210/endo-124-3-1576
Kunstadter, 1961, Norethandrolone in children with and without cystic fibrosis of the pancreas, Ill Med J., 120, 156
Good, 1966, Anabolic Steroids in Cystic Fibrosis of the Pancreas, Am J Dis Child., 111, 272
Dooley, 1969, Norethandrolone in cystic fibrosis of the pancreas, J Paediatr., 74, 95, 10.1016/S0022-3476(69)80013-2
Varness, 2009, Oxandrolone Improves Height Velocity and BMI in Patients with Cystic Fibrosis, Int J Pediatr Endocrinol., 2009, 826895, 10.1186/1687-9856-2009-826895
Thaker, 2014, Recombinant growth hormone therapy for cystic fibrosis in children and young adults (Review), Cochrane Libr.
Street, 2006, Inflammation is a modulator of the insulin-like growth factor (IGF)/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis, Eur J Endocrinol., 154, 47, 10.1530/eje.1.02064
Sermet-Gaudelus, 2003, Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients, Arch Dis Child., 88, 956, 10.1136/adc.88.11.956
Takala, 1999, Increased mortality associated with growth hormone treatment in critically ill adults, N Engl J Med., 341, 785, 10.1056/NEJM199909093411102
Hoeben, 2004, Vascular Endothelial Growth Factor and Angiogenesis, Pharmacol Rev., 56, 549, 10.1124/pr.56.4.3
Meffert, 1966, Hormonal Control of Collateral Circulation, Circ Res., 18, 228, 10.1161/01.RES.18.2.228
Pope, 2004, Anabolic steroid users’ attitudes towards physicians, Addiction., 99, 1189, 10.1111/j.1360-0443.2004.00781.x